Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension

Journal of Hypertension

Volumn 14, Issue 1, 1996, Pages 137-144

  Mallion, Jean Michel ^a,c   Dutrey Dupagne, Claire ^b   Vaur, Laurent ^b   Genes, Nathalie ^b   Renault, Maguy ^b   Elkik, François ^b   Baguet, Philippe ^a   Boutelant, Sophie ^a  

^a CHU La Tronche and University   (France)

^b Laboratoires Roussel   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antihypertensive treatment; Clinical trial; Compliance; Electronic monitoring; Hypertension; Trandolaparil

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ELECTRONICS; FEMALE; FRANCE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MICROPROCESSOR; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TIME;

EID: 0029983765     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sackett DL, Gibson ES, Taylor DW, Haynes RB, Hackett BC, Roberts RS, et al.: Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975, i:1205-1207.
2. Perry HM, Camel GH: Survival of treated hypertensive patients as a function of compliance and control. J Hypertens 1984, 2 (suppl 3): 197-199.
3. Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL: Patient compliance with antihypertensive regimens. Patients' Council. Health Educ 1978, 1:18-21.
4. Briggs WA, Lowenthal DT, Cirksena WJ, Price WE, Gibson TP, Flamenbaum W: Propranolol in hypertensive dialysis patients: efficacy and compliance. Clin Pharmacol Ther 1976, 18:606-612.
5. Psaty BM, Koepsell TD, Wagner EH, LoGerto JP, Inui TS: The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA 1990, 263:1653-1657.
6. Stewart M : The validity of an interview to assess a patient's drug taking. Am J Prev Med 1987, 3:95-100.
7. Rudd P, Byyny RL, Zachary V, LoVerde ME, Mitchell WD, Titus C, et al: PIII count measures of compliance In a drug trial: variability and suitability. Am J Hypertens 1988, 1:309-312.
8. Pullar T, Kumar S, Tindal H, Feely M: Time to stop counting the tablets? Clin Pharmacol Ther 1989, 46:163-166.
9. Kruse W, Weber E: Dynamics of drug regimen compliance: its assessment by microprocessor-base monitoring. Eur J Clin Pharmacol 1990, 38:561-565.
10. Mallion JM, Meilhac B, Tremel F, Calvez R, Bertholom N: Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol 1992, 19 (suppl 2):S41-S48.
11. Wei L, Clauser E, Alhene Gelas F, Corvol P: The two homologous domains of human anglotensin 1-converting enzyme interact differently with competitive inhibitors. J Biol Chem 1992, 267:13398-13405.
12. Cesarone MR, De Sanctis MT, Laurora G, Ambroseli L, Marelli C, Belcaro G: Effects of trandolapril on 24-h ambulatory blood pressure in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 1994, 23 (suppl 4):S65-S72.
13. Vaur L, Dubroca I, Dutrey-Dupagne C, Elkik F: Influence of a missed dose on blood pressure control in hypertensives treated with ACE inhibitors. Am J Hypertens 1994, 7:35A.
14. Guidelines Sub Committee of the WHO/ISH mild hypertension liaison committee: 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993, 11:905-918.
15. Jamieson MJ, Webster J, Witte K, Huggins MM, McDonald TM, de Beaux A et al.: An evaluation of the A & D UA-751 semi-automated cuff-oscillometric sphygmomanometer. J Hypertens 1990, 8:377-381.
16. Averbuch M, Weintraub M, Pollock DJ: Compliance assessment in clinical trials: the MEMS device. J Clin Res Pharmacoepidemiol 1990, 4:199-204.
17. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF: Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993, 6:586-592.
18. Rudd P, Ahmed S, Zachary AS, Barton C, Bonduelle D: Improved compliance measures: applications in an ambulatory hypertensive trial. Clin Pharmacol Ther 1990, 48:676-685.
19. McClellan WM, Dallas Hall WD, Brogan D, Miles C, Wilber JA: Continuity of care in hypertension. Arch Intern Med 1988, 148:525-528.
20. Edmons D, Foerster E, Groth H, Greminger P, Siegenthaler W, Veter W: Does self measurement of blood pressure improve compliance in hypertension? J Hypertens 1985, 3 (suppl 1):31-34.
21. Sassano P, Chatellier G, Alhenc-Gelas F, Corvol P, Ménard J: Antihypertensive effect of enalapril as first-step treatment of mild and moderate uncomplicated essential hypertension. Am J Med 1984, 77:18-22.
22. Kownater S, Dutrey-Dupagne C, Vaur L, Chevrier J, Diesel J, D'Hôtel R et al.: Durée d'action du trandolapril chez l'hypertendu léger à modéré, évaluée par mesure ambulatoire de la pression artérielle. Thérapie 1994, 49:89-93.
23. Rudd P, Ryyny RL, Zachary V, LoVerde ME, Titus C, Mitchell WD et al.: The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989, 46:169-176.
24. Meredith PA, Elliott HL: Therapeutic coverage: reducing the risks of partial compliance. Br J Clin Pract 1994, 73:13-17.
25. Muller JE, Tofler GH, Stone PH: Circadian variations and triggers of onset of acute cardiovascular disease. Circulation 1989, 79:733-743.